Showing 2121-2130 of 3223 results for "".
- Allergan Teams Up With Super Bowl MVP Von Miller to Raise Awareness of Glaucoma’s Impact on Daily Livinghttps://modernod.com/news/allergan-teams-up-with-super-bowl-mvp-von-miller-to-raise-awareness-of-glaucomas-impact-on-daily-living/2477236/Allergan announced a partnership with Von Miller, Super Bowl MVP, Denver Broncos linebacker, and advocate for healthy vision, to shine a light on the millions of people living with glaucoma. As an ambassador for the ‘My Glaucoma’ campaign, Mr. Miller wil
- AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisitionhttps://modernod.com/news/abbvie-announces-leadership-team-and-creation-of-new-business-allergan-aesthetics-upon-completion-of-acquisition/2477216/AbbVie announced the creation of a new global business, Allergan Aesthetics, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition. Allergan Aesthetics will operate as a new global dedicated business wit
- Allergan Foundation Giving Reaches $95 Million Since Inceptionhttps://modernod.com/news/allergan-foundation-giving-reaches-95-million-since-inception/2477188/Allergan announced that The Allergan Foundation has awarded a total of $10 million in charitable grants in 2019. The grants were donated to more than 400 organizations in 32 states as part of The Allergan Foundation’s commitment to providing a lasting and posit
- Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 GUARD Trial for Prevention of Proliferative Vitreoretinopathyhttps://modernod.com/news/aldeyra-therapeutics-announces-first-patient-enrolled-in-the-phase-3-guard-trial-for-prevention-of-proliferative-vitreoretinopathy/2477182/Aldeyra Therapeutics announced enrollment of the first patient into the phase 3 GUARD Trial of ADX-2191 for the prevention of proliferative vitreoretinopathy (PVR). PVR is a serious, sight-threatening retinal disease with no approved treatment. “Initiation of patient enrollment in the GUAR
- Trump Administration Advances Plan to Allow Certain Prescription Drug Imports From Canadahttps://modernod.com/news/trump-administration-advances-plan-to-allow-certain-prescription-drug-imports-from-canada/2477183/The US Department of Health and Human Services (HHS) said the Trump administration is pushing ahead with a plan to allow certain prescription drugs to be imported from Canada. “For the first time in history HHS and FDA are open to importation as a means for lower prices,” co
- Staar Surgical Announces Strategic Alliance Agreement with California Center for Refractive Surgery (CCRS)https://modernod.com/news/staar-surgical-announces-strategic-alliance-agreement-with-california-center-for-refractive-surgery-ccrs/2477178/Staar Surgical announced it has entered into a strategic alliance with the California Center for Refractive Surgery (CCRS), a Los Angeles based eye care group with locations in Hancock Park and Sherman Oaks. “Our new multi-clinic alliance with CCRS and its founder Dr. Paul Lee is represent
- Aldeyra Therapeutics Announces Topline Results from Part 1 of Adaptive Phase 3 RENEW Trial in Dry Eye Diseasehttps://modernod.com/news/aldeyra-therapeutics-announces-positive-topline-results-from-part-1-of-adaptive-phase-3-renew-trial-in-dry-eye-disease/2477138/Aldeyra Therapeutics announced positive topline results from Part 1 of the adaptive phase 3 RENEW trial of topical ocular reproxalap in patients with dry eye disease, according to a company news release. “To our knowledge, reproxalap is the first topical dry eye disease drug to demonstrate
- Study Shows Superior Success Rate for ExTra ELT Compared With Trabectome in Patients With Glaucoma Plus Cataract Surgeryhttps://modernod.com/news/study-shows-superior-success-rate-for-extra-elt-compared-with-trabectome-in-patients-with-glaucoma-plus-cataract-surgery/2477135/ELT Sight announced that in the largest published study to date on excimer laser trabeculostomy (ELT), the ExTra ELT procedure plus cataract surgery was superior to ab interno trabeculectomy with the Trabectome plus cataract surgery, according to a company news release. The 245-patient
- Alcon to Hold Second Annual Alcon Retina Fellows Institutehttps://modernod.com/news/alcon-to-hold-second-annual-alcon-retina-fellows-institute/2477120/Alcon announced it will host future ophthalmology leaders for the second annual Alcon Retina Fellows Institute, an educational experience where first year retina fellows gain hands-on surgical training and mentorship from some of the leading ophthalmologists in the field, according to a company n
- EyePoint Pharmaceuticals Appoints George O. Elston as Chief Financial Officer and Head of Corporate Developmenthttps://modernod.com/news/eyepoint-pharmaceuticals-appoints-george-o-elston-as-chief-financial-officer-and-head-of-corporate-development/2477091/EyePoint Pharmaceuticals announced the appointment of George O. Elston as Chief Financial Officer and Head of Corporate Development. Mr. Elston has previously been a consultant to the company and will now transition into this permanent role effective immediately. In this role, Mr. Elston will lea